Use of methylene amide derivatives in cardiovascular disorders
Details for Australian Patent Application No. 2005216649 (hide)
International Classifications
Event Publications
24 August 2006 PCT application entered the National Phase
PCT publication WO2005/082347 Priority application(s): WO2005/082347
9 November 2006 Change of Name(s) of Applicant(s), Section 104
Apllied Research Systems ARS Holding N.V. The name of the applicant has been changed to Applied Research Systems ARS Holding N.V.
25 October 2007 Assignment before Grant
Applied Research Systems ARS Holding N.V The application has been assigned to Laboratoires Serono SA
30 April 2009 Alteration of Name
The name of the applicant has been altered to Merck Serono SA
9 September 2010 Application Accepted
Published as AU-B-2005216649
13 January 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005216651-Treatment of interstitial cystitis with vitamin D compounds
2005216648-Hyaluronic acid derivative based threedimensional matrix
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser